ORIX (IX) Receives Daily Coverage Optimism Rating of 0.16

News articles about ORIX (NYSE:IX) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. ORIX earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned media headlines about the real estate investment trust an impact score of 45.6976545585076 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Separately, Zacks Investment Research downgraded ORIX from a “buy” rating to a “sell” rating in a report on Tuesday, September 26th.

ORIX (IX) traded up $0.73 on Friday, hitting $89.09. The stock had a trading volume of 22,872 shares, compared to its average volume of 20,686. ORIX has a 12 month low of $73.70 and a 12 month high of $89.51. The company has a quick ratio of 1.47, a current ratio of 1.50 and a debt-to-equity ratio of 1.41. The firm has a market capitalization of $23,470.00, a P/E ratio of 8.75, a P/E/G ratio of 1.05 and a beta of 1.49.

TRADEMARK VIOLATION WARNING: “ORIX (IX) Receives Daily Coverage Optimism Rating of 0.16” was originally posted by Equities Focus and is the sole property of of Equities Focus. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.equitiesfocus.com/2018/01/06/orix-ix-receives-daily-coverage-optimism-rating-of-0-16.html.

About ORIX

Insider Buying and Selling by Quarter for ORIX (NYSE:IX)

Receive News & Ratings for ORIX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ORIX and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply